Deeper Data and Analysis to Improve Diagnosis and Next Steps

We have a deep legacy of diagnosing complex disorders of the nervous system and use whole genome and whole exome next generation sequencing as the basis for our genomic analysis.

Learn About Our Tests

Who We Are

QnA Dx is a CLIA/ISO-15189 accredited clinical sequencing laboratory located in Cambridge, MA. We are a subsidiary of Q-State Biosciences, a precision medicine company working to develop genetically targeted and transformative therapies for severe disorders of the nervous system.

Our Approach

Our goal is to empower physicians with the best available whole genome and exome technology and analysis, thereby improving their ability to diagnose and provide best next steps for their patients. We work with several sequencing and data analysis platforms to deeply probe the underlying cause of disease.

Learn More

Our Tests

Our tests derive from a whole genome or exome backbone, enabling us to sequence once and analyze often. We enhance our test results by including analysis of copy number variants, repeat expansions, and structural variants. Choose one of our neurology-focused enhanced panels or go directly to enhanced exome analysis.

Learn More